Spots Global Cancer Trial Database for adverse events
Every month we try and update this database with for adverse events cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) | NCT01436240 | Cancer | questionnaire a... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer | NCT05311566 | Cervical Carcin... Chemoradiothera... Anti-programmed... Immunotherapy Immune Checkpoi... Survival Outcom... Adverse Events Early Stage Cer... Locally Advance... | Camrelizumab pl... | 18 Years - | Peking Union Medical College Hospital | |
| Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma | NCT02725073 | Treatment Respo... Adverse Events Feasibility | Photodynamic th... | 19 Years - | Asan Medical Center | |
| Testing a Spanish Version of a Patient Toxicity Questionnaire | NCT01517152 | Breast Cancer Colon Cancer Lung Cancer Lymphoma Myeloma | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients | NCT04528745 | Pancreas Cancer Colorectal Canc... | Bio Impedance S... | 18 Years - | University of Copenhagen | |
| Nutritional Support During Induction Therapy for Esophageal Cancer | NCT05314946 | Esophageal Canc... Nutrition Aspec... | No feeding tube... Placement of a ... | 18 Years - | Lawson Health Research Institute | |
| Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) | NCT01436240 | Cancer | questionnaire a... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Responsible Side Effects Management in Oncology | NCT04623437 | Pharmacovigilan... Oncology Antineoplastic ... | 18 Years - 75 Years | University Hospital "Sestre Milosrdnice" | ||
| Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer | NCT02091661 | Prostate Cancer | Radical retropu... External beam r... | - 75 Years | University of Rome Tor Vergata | |
| Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer | NCT05310344 | Ovarian Carcino... Platinum-resist... Recurrent Ovari... Albumin-bound P... Bevacizumab Survival Outcom... Adverse Events | Albumin-bound p... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS) | NCT06361784 | Locally Advance... | - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | ||
| Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE | NCT01291667 | Progress-free S... Overall Respons... Adverse Events | 18 Years - 70 Years | Shanghai CP Guojian Pharmaceutical Co., Ltd. | ||
| Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis | NCT04810156 | Hepatitis, Drug... | Mycophenolate M... Solu-Medrol Ursodeoxycholic... Prednisone tabl... | 18 Years - | Herlev Hospital | |
| Melatonin as Adjuvant Therapy in Breast Cancer Patients | NCT01557478 | Stage II and II... | Melatonin match placebo | 18 Years - 70 Years | Khon Kaen University | |
| Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies | NCT05448222 | Hepatocellular ... Sarcopenia | Diagnostic Test... | 18 Years - 80 Years | First Affiliated Hospital of Wenzhou Medical University | |
| An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer | NCT01860144 | Metastatic Colo... | Bevacizumab | - | Peking University | |
| Evaluation of Side Effects of Mitotane | NCT00568139 | Adrenocortical ... | - | University of Wuerzburg | ||
| Factors Related to Adverse Events in Colorectal Cancer | NCT02488161 | Colorectal Canc... | No intervention | 18 Years - | Hospital Galdakao-Usansolo | |
| A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study | NCT04641247 | Ovarian Neoplas... Breast Neoplasm... | Niraparib | 18 Years - | GlaxoSmithKline | |
| Adverse Events During Upper Gastrointestinal Endoscopy | NCT01979549 | Patients Need U... Peptic Ulcer Gastric Cancer Esophagus Cance... Oesophagitis | 18 Years - | RenJi Hospital | ||
| Niraparib Plus Anlotinib for Recurrent Ovarian Cancer | NCT05311579 | Ovarian Carcino... Survival Outcom... Adverse Events Niraparib Anlotinib CA125 Chemotherapy Targeted Therap... Recurrent Ovari... | Niraparib plus ... | 18 Years - | Peking Union Medical College Hospital | |
| Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer | NCT06274879 | Bile Duct Cance... | Gemcitabin, Cis... Biliary Radiofr... Endoscopic Retr... | 18 Years - | Insel Gruppe AG, University Hospital Bern | |
| Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies | NCT05448222 | Hepatocellular ... Sarcopenia | Diagnostic Test... | 18 Years - 80 Years | First Affiliated Hospital of Wenzhou Medical University | |
| Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study) | NCT06238596 | Metastatic Pros... Rehabilitation | rehabilitation | 18 Years - | Azienda Unità Sanitaria Locale Reggio Emilia | |
| Tris-CAR-T Cell Therapy for Recurrent Glioblastoma | NCT05577091 | Recurrent Gliob... | Inverse correla... | 18 Years - 70 Years | Beijing Tiantan Hospital | |
| Melatonin In Reduction of Chemotherapy-Induced Toxicity (MIRCIT) Trial | NCT01706627 | Advanced Stage ... | 10 mg Melatonin 20 mg Melatonin Matched placebo | 18 Years - 70 Years | Khon Kaen University | |
| Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL | NCT03707847 | ALK-Positive An... | Crizotinib Etoposide Capsu... Auto-HSCT | 14 Years - 65 Years | Zhengzhou University | |
| Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study) | NCT06238596 | Metastatic Pros... Rehabilitation | rehabilitation | 18 Years - | Azienda Unità Sanitaria Locale Reggio Emilia | |
| Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia | NCT00304447 | Leukemia, Myelo... Infusions, Intr... | Mylotarg | 18 Years - | Wyeth is now a wholly owned subsidiary of Pfizer | |
| A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma | NCT04831658 | Primary Central... | the dose-escala... | 18 Years - 69 Years | Zhengzhou University | |
| Responsible Side Effects Management in Oncology | NCT04623437 | Pharmacovigilan... Oncology Antineoplastic ... | 18 Years - 75 Years | University Hospital "Sestre Milosrdnice" | ||
| A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma | NCT04831658 | Primary Central... | the dose-escala... | 18 Years - 69 Years | Zhengzhou University | |
| Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer | NCT05310344 | Ovarian Carcino... Platinum-resist... Recurrent Ovari... Albumin-bound P... Bevacizumab Survival Outcom... Adverse Events | Albumin-bound p... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy | NCT04327583 | Advanced or Met... Relapsed Hemato... | IPPACTTO | 18 Years - | Institut Cancerologie de l'Ouest | |
| Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer | NCT06274879 | Bile Duct Cance... | Gemcitabin, Cis... Biliary Radiofr... Endoscopic Retr... | 18 Years - | Insel Gruppe AG, University Hospital Bern | |
| PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study | NCT05377320 | Heart Failure Coronary Artery... Peripheral Arte... Ischemia Hypertension Diabetes Mellit... Cardiomyopathie... Cardiotoxicity | Clinical Decisi... Standard Care | 18 Years - | Medical College of Wisconsin | |
| Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) | NCT02158637 | Cancer | 18 Years - | Mayo Clinic | ||
| Adverse Events During Upper Gastrointestinal Endoscopy | NCT01979549 | Patients Need U... Peptic Ulcer Gastric Cancer Esophagus Cance... Oesophagitis | 18 Years - | RenJi Hospital | ||
| An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer | NCT01860144 | Metastatic Colo... | Bevacizumab | - | Peking University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
